Outpatient esophageal variceal sclerotherapy: safe and cost-effective. A prospective study.
A study to determine the safety and cost-effectiveness of outpatient esophageal variceal sclerotherapy (EVS) was undertaken between May 1983 and April 1984. A total of 117 EVS treatments were performed on 34 patients. Complications were minor and no patients required immediate hospitalization following treatment. A cost benefit was realized with outpatient EVS compared to inpatient EVS.
D000328:Adult; D000553:Ambulatory Care / Q000191:economics; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005233:Fatty Alcohols / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011446:Prospective Studies; D012981:Sodium Tetradecyl Sulfate / Q000627:therapeutic use*
D005233:Fatty Alcohols; D012981:Sodium Tetradecyl Sulfate